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Abstract
Winchester syndrome (WS, MIM #277950) is an extremely rare autosomal recessive skeletal dysplasia characterized by
progressive joint destruction and osteolysis. To date, only one missense mutation in MMP14, encoding the membrane-bound
matrix metalloprotease 14, has been reported in WS patients. Here, we report a novel hypomorphic MMP14 p.Arg111His
(R111H) allele, associated with a mitigated form of WS. Functional analysis demonstrated that this mutation, in contrast to
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previously reported human and murine MMP14 mutations, does not affect MMP14’s transport to the cell membrane. Instead,
it partially impairs MMP14’s proteolytic activity. This residual activity likely accounts for the mitigated phenotype observed
in our patients. Based on our observations as well as previously published data, we hypothesize that MMP14’s catalytic activ-
ity is the prime determinant of disease severity. Given the limitations of our in vitro assays in addressing the consequences of
MMP14 dysfunction, we generated a novel mmp14a/b knockout zebrafish model. The fish accurately reflected key aspects of
the WS phenotype including craniofacial malformations, kyphosis, short-stature and reduced bone density owing to defec-
tive collagen remodeling. Notably, the zebrafish model will be a valuable tool for developing novel therapeutic approaches to
a devastating bone disorder.
Introduction
In 2007, we reported two Dutch brothers with an autosomal re-
cessive disorder consisting of dysmorphic facial features, mitral
valve prolapse, severe acne and reduced bone density (1). We
diagnosed them with Borrone syndrome, as their phenotype
strongly resembled that of two patients first described by Borrone
et al. (2). Symptoms in our patients were less severe, which we at-
tributed to their younger age compared with Borrone’s patients
at the time of diagnosis. However, in the intervening years since
diagnosis their phenotype has not appreciably worsened, sug-
gesting that it is intrinsically milder.
In the patients originally reported by Borrone et al., we
recently identified a homozygous splice site mutation in
SH3PXD2B (3). Thus, Borrone syndrome is no longer considered
as a separate entity, but as allelic to Frank-Ter Haar syndrome
(FTHS, MIM #249420) (4). SH3 and Phox-homology (PX) Domain-
containing Protein 2B (SH3PXD2B, also known as TKS4) is an
adapter protein required for functionality of podosomes (5).
These are actin-rich membrane structures that mediate adhe-
sion and invasive motility in a variety of cell types. Specifically,
upon phosphorylation by c-SRC, SH3PXD2B recruits the
membrane-bound matrix metalloprotease 14 (MMP14, also
known as MT1-MMP) to the nascent podosome membrane (6).
Here, MMP14 hydrolyzes intact fibrillar collagen and activates
downstream effectors, including the gelatinase matrix metallo-
proteinase 2 (MMP2) that in turn can further degrade frag-
mented collagen fibrils (7–9). MMP14’s collagenolytic activity is
thought to be one of its most important functions in vivo, for
which homodimerization is required (10). Loss of either MMP2
or MMP14 results in a spectrum of recessive skeletal dysplasias
with osteolysis, encompassing multicentric osteolysis, nodulo-
sis and arthropathy (MONA, MIM #259600) and Winchester syn-
drome (WS, MIM #277950). These disorders exhibit significant
clinical overlap. Notably, WS is associated with mutations in
MMP2 as well as in MMP14 (11,12).
In our patients, we found no mutation or deletion of
SH3PXD2B. Subsequent homozygosity mapping and next-
generation sequencing identified a novel homozygous missense
mutation in MMP14, c.332G>A (www.LOVD.nl/MMP14), which
was predicted to result in the substitution p.Arg111His (R111H;
see Supplementary Material, Methods and Fig. S1) and assessed
as possibly damaging by multiple algorithms (data not shown).
Accordingly, we revised our patients’ diagnosis to WS, pending
confirmation of the mutation’s pathogenicity.
MMP14 encodes a membrane-bound metalloprotease that
requires removal of an N-terminal pro-domain sequence for its
activation and presentation at the cell surface (13). The pro-
domain has two furin cleavage motifs, R89–R–P–R–C93 and R108–
R–K–R–Y112. Previously published work suggests that the
latter motif is cleaved to generate the active enzyme (13,14).
Therefore, we reasoned that the R111H mutation might
interfere with cleavage and thereby impair MMP14 membrane
localization and activation.
To test our hypothesis, we analyzed the consequences of the
R111H change for MMP14’s intracellular processing and func-
tionality, comparing with known mutations associated with WS
and similar mouse phenotypes. To better understand the con-
nection between loss of MMP14 activity and the clinical mani-
festations of WS, we additionally generated a knockout (KO)
zebrafish model. Our findings provide novel insights into the
pathogenesis of the WS phenotype, with potential consequen-
ces for therapy.
Results
An in vitromodel for assessing MMP14 processing and
subcellular localization
To examine MMP14 processing, we created a construct encoding
either wild-type (WT) or mutant human pro-MMP14 with an
N-terminal triple (3)-HA tag and a C-terminal enhanced green
fluorescent protein (EGFP) (resulting in the fusion protein 3HA–
MMP14–EGFP, Fig. 1A). Given correct processing of MMP14, the
3HA tag should not be detectable in a similar location to EGFP.
The EGFP signal, on the other hand, should be visible at the
Golgi/trans-Golgi network, the cell membrane and along the
route by which the protein traffics. Aberrant processing and
subsequent abnormal trafficking ought to be reflected in an al-
tered subcellular distribution of both tags. Fusion proteins were
exogenously expressed in MRC-5V1 immortalized human fetal
lung fibroblasts (hereafter termed MRC5) and compared with
control of 3HA–EGFP (Fig. 1B). This cell type is a good model for
the disease phenotype, which includes connective tissue and
lung abnormalities in humans and mouse models, respectively
(15,16). Immunoblotting with a commercially available antibody
demonstrated that MRC5 cells have very low endogenous
MMP14 expression (Supplementary Material, Fig. S2). Thus,
mutant protein localization is unlikely to be affected by dimer-
ization with endogenous MMP14. Next, we determined that
the localization of exogenously expressed double-tagged
MMP14-WT was very similar to that of endogenous MMP14
(Supplementary Material, Fig. S3). Having established that our
tagging strategy did not affect protein localization, we next
compared and contrasted MMP14-WT and MMP14-R111H with
previously characterized MMP14 missense mutants to deter-
mine why our patients’ phenotype was comparatively mild.
MMP14 R111H is processed normally and is trafficked to
the cell surface
As shown in Figure 1C and Supplementary Material, Fig. S4,
MMP14–R111H–EGFP (panel iv) localizes in a similar manner to
that observed for MMP14–WT–EGFP (panel i). The lack of any HA
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Figure 1. The R111H mutation does not impair MMP14 cell surface localization, in contrast to mutations T17R, R92C and S466P. (A) Schematic representation of the
MMP14 fusion protein with N-terminal triple (3)-HA tag and C-terminal EGFP. Both tags are attached to MMP14 by flexible linkers (horizontal black lines). Indicated are
the mutations relative to the protein domains. (B) Schematic representation of the 3HA–EGFP fusion protein which served as control. (C) Subcellular localization of WT
and mutant 3HA–MMP14–EGFP fusion proteins exogenously expressed in MRC5 cells. MMP14-WT-EGFP (i) and MMP14-R111H-EGFP (iv) are present in the perinuclear
region and at the cell surface, whereas the HA tag is absent at the cell surface. For other mutant fusion proteins, cell surface localization is impaired and the two tags
partially colocalize in the perinuclear region. Scale bar equals 20 mm.
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signal at the cell membrane suggests that R111H does not mark-
edly impact removal of the signal peptide. In western blot (WB)
analysis [Fig. 2A, lane 2 (WT) and lane 5 (R111H)] the banding
pattern of R111H was similar to that of WT, with EGFP signal in-
dicating removal of the HA tag and subsequent further process-
ing of the resultant protein.
The human mutation p.Thr17Arg (T17R) has previously been
reported as causing WS (12). This substitution is located within
the conserved N-terminal signal peptide sequence of MMP14.
T17R is thought to prevent proper localization to the ER
and subsequent processing of MMP14. Accordingly, whilst the
pro-enzyme was observed at the cell membrane by membrane
fractionation and surface biotinylation, there was an absence of
active MMP14 (12). We did not observe the T17R mutant at the
cell membrane by immunofluorescence [IF, Fig. 1C(ii) and
Supplementary Material, Fig. S4(ii)], most likely owing to differ-
ences in sensitivity between assays used. Rather, we found
MMP14 T17R distributed throughout the cytoplasm. The (partial)
co-localization of HA and EGFP tags observed by IF, as well as
the overlapping HA and EGFP bands observed by WB (Fig. 2A,
lane 3) suggest that the T17R mutation impairs MMP14’s signal
sequence removal.
Figure 2. The R111H mutation does not affect MMP14 posttranslational processing, in contrast to mutations T17R, R92C and S466P, yet partially impairs enzymatic and
cell migration stimulatory activity. (A) Immunoblot with anti-HA (top panel) or anti-GFP (middle panel) antibodies assessing the post-translational processing of WT
and mutant 3HA–MMP14–EGFP fusion proteins exogenously expressed in MRC5 cells. For all fusion proteins, the full-length pro-protein (pM) can be detected. For all ex-
cept the T17R mutant, an additional form (cM) can be detected in which the HA tag has been removed. Additional degradation products (dM) can only be detected in
MMP14-WT and MMP14-R111H expressing cells. In cells expressing 3HA–EGFP, a strong band corresponding to the fused tags can be detected (HE). (B) Gelatin zymogra-
phy of media conditioned by MRC5 cells exogenously expressing the WT or mutant 3HA–MMP14–EGFP fusion proteins. Cells expressing 3HA–EGFP control do not acti-
vate pro-MMP2 (p2), whereas MMP14-WT expressing cells activate pro-MMP2 to its intermediate (i2) and active (a2) form. The T17R and R92C mutations completely
abolish pro-MMP2 activation, whereas the R111H and S466P mutants retain residual activity. Expression of MMP14 fusion proteins does not affect activation of pro-
MMP9 (p9 and a9). (C) Average degraded Cy3-gelatin surface area per MMP14 fusion protein expressing MRC5 cell at 4 h (grey bars) and 20 h (black bars) post-seeding.
The R92C mutation completely abolishes gelatin degradation, whereas the R111H mutant retains some residual activity. In contrast, the T17R and S466P mutations do
not impair gelatin degradation. Error bars indicate SEM of biological triplicates. (D) Average migration rate of MMP14 fusion protein expressing MRC5 cells on fibronec-
tin. Expression of MMP14-WT significantly stimulates migration compared with 3HA–EGFP expression, whereas the T17R, R92C and R111H mutations impair this stim-
ulatory effect. In contrast, the S466P mutation does not affect MMP14-dependent migration. Significance levels: dot, P<0.05; double dot, P<0.01, triple dot, P<0.001.
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To further probe the relationship between MMP14 domains
and disease, we generated double-tagged human versions of
two MMP14 mutants associated with murine phenotypes that
strongly resemble WS. The corresponding mutations are located
in distinct MMP14 domains yet cause disorders that are virtually
indistinguishable. The p.Arg92Cys (R92C) substitution, underly-
ing the small and bugged-eyed (Sabe) phenotype, affects a con-
served R89–R–P–R–C93 furin cleavage motif (17). As seen in
Figure 1C(iii) and Supplementary Material, Figure S4(iii),
MMP14–R92C–EGFP was absent from the cell membrane, sug-
gesting that R92C might impair the prodomain processing that
is required for cell surface localization. The removal of the HA
tag was confirmed by WB (Fig. 2A, lane 4), however, the lack of
any additional bands suggests that R92C impairs subsequent
processing of MMP14.
The second murine mutation, p.Ser466Pro (S466P), causes
the Cartoon phenotype (18). Serine 466 is a highly conserved resi-
due in blade 4 of MMP14’s hemopexin (Hx)-like domain, which
is required for enzyme maturation and trafficking as well as for
homodimer interactions (19,20). Figure 1C(v) shows extensive
perinuclear co-localization of HA and EGFP in cells expressing
HA–MMP14–S466P–EGFP. Membrane localization of S466P mu-
tant protein [Supplementary Material, Fig. S4(v)] was markedly
reduced compared with WT (and R111H). S466P does not seem
to affect the removal of the SP and HA tag (Fig. 2A, lane 6), al-
though the reduced intensity of lower bands when compared
with those observed for MMP14-WT and R111H suggests that
this single amino acid substitution in the Hx domain compro-
mises MMP14 processing.
MMP14 R111H retains partial pro-MMP2 hydrolyzing
activity
Since MMP14-R111H seemed to be processed and trafficked nor-
mally, we next assessed the functionality of this mutant with
respect to pro-MMP2 activation, utilizing gelatin zymography
(7). First, we determined that medium conditioned by 3HA–EGFP
expressing MRC5 cells did not activate pro-MMP2 (Fig. 2B, lane
6), consistent with low endogenous MMP14 levels in these cells.
Subsequently, we assessed the pro-MMP2 activating potential
of media conditioned by cells expressing the tagged WT or mu-
tant MMP14 fusion proteins. As shown in Figure 2B, conditioned
media from cells expressing the WT fusion protein converts
pro-MMP2 to its intermediate and active forms (lane 1), indicat-
ing that the exogenously expressed WT fusion protein is func-
tionally active. Both R111H (Fig. 2B, lane 4) and S466P (lane 5)
mutants retained partial activity. In contrast, T17R (Fig. 2B, lane
2) as well as R92C (lane 3) abrogated pro-MMP2 processing.
MMP14 R111H retains partial gelatinolytic activity
MMP14 has a key role in mediating invasive cell behavior (7).
Thus, we determined the effect of MMP14 mutations on inva-
sive extracellular matrix (ECM) degradation. We used Millipore’s
QCMTM Gelatin Invadopodia Assay system (Cat. No. ECM671)
combined with live cell imaging. The results are summarized in
Figure 2C, indicating the extent to which MRC5 cells expressing
WT or mutant tagged MMP14 were capable of digesting the gela-
tin matrix on which they were seeded. In line with our previous
localization and zymography data, the expression of MMP14-
WT resulted in significantly more gelatin degradation than ex-
pression of 3HA–EGFP. R92C abolished all gelatinase degrada-
tion, whereas R111H resulted in a significant reduction yet
retained partial activity. Intriguingly, in this assay the S466P
mutant retained full activity when compared with the WT pro-
tein, despite membrane localization for this mutant being
impaired.
MMP14 R111H has a reduced cell migration stimulatory
potential
The gelatin invadopodia assay could not be used to assess
MMP14’s ability to promote cellular migration. We repeatedly
observed that cells expressing tagged MMP14 seemed to adhere
strongly to the poly-L-lysine coated coverslip in areas where gel-
atin was degraded, such that when the cells finally did move,
fragments of cell membrane were left behind (data not shown)
resulting in cell death. We hypothesized that abnormal cell mi-
gration might contribute to the disease phenotype, as knock-
down of sh3pxd2a was previously observed to reduce the
migrational velocity and podosome formation of zebrafish neu-
ral crest cells, resulting in craniofacial malformations (21). We
therefore subjected cells expressing WT or mutant MMP14 fu-
sion proteins to a phagokinetic assay as previously described
(22). Given the cells’ strong adherence to gelatin, we used fibro-
nectin (1 mg/ml) as the substrate. As shown in Figure 2D, the
T17R, R92C and R111H mutants demonstrated significantly re-
duced migratory behavior when compared with MMP14-WT,
however, without showing a clear correlation with the severity
of the associated clinical phenotypes. Unexpectedly, motility of
cells expressing MMP14-S466P was not impaired compared with
MMP14 WT expressing cells.
KO ofmmp14a/b in Danio rerio recapitulates key aspects
of the WS phenotype
Our observations suggest that loss of MMP14’s catalytic activity
might be a prime determinant of the WS phenotype. To better
understand this link, we decided to generate a zebrafish (Danio
rerio) KO model of WS. Danio rerio is a well-established verte-
brate model system for the study of ossification and has several
advantages over mice, such as rapid external embryonic devel-
opment, the ability to generate large numbers of offspring and
relatively low cost (23,24). MMP14 is well conserved between
humans and zebrafish, consistent with significant functional
overlap even though the latter have two copies, mmp14a and
mmp14b, owing to genomic duplication (25,26). Previous work
using morpholino oligonucleotide (MO)-mediated knockdown
suggested that loss of mmp14a expression results in defective
craniofacial morphogenesis, and hinted at abnormal matrix
composition of craniofacial cartilage Anlagen. Observations on
the consequences of mmp14b knockdown are conflicting. It has
been proposed that mmp14a and mmp14b might have a role in
cellular migration during gastrulation (25,27). However, it was
later shown that this was probably a p53-mediated off-target
MO effect, although additional non-p53-dependent off-target
apoptosis might have contributed as well (28,29).
In light of these considerations, and because our data indi-
cate that the mutation in our patients causes a loss of function,
using CRISPR/Cas9 we knocked out mmp14a and mmp14b in
zebrafish (30). Targeting Exon 4 in both mmp14a and mmp14b
genes resulted in the introduction of 2bp and 8bp deletions, re-
spectively (Supplementary Material, Fig. S5A), which are pre-
dicted to cause a frameshift and premature stop (p.S183Rfs23X
and p.F190X, respectively). Using qPCR, we showed that the
resulting mutant mRNA undergoes nonsense-mediated decay







g/article-abstract/27/16/2775/4993964 by guest on 05 N
ovem
ber 2018
(Supplementary Material, Fig. S5B and C). We further confirmed
that any residual protein product would not contain the WT
sequence C-terminal to the mutation site (Supplementary
Material, Fig. S5D).
In subsequent crosses, fish with all possible combinations of
WT and mutant mmp14a/b alleles were generated. Independent
of the parental genotype, mmp14aD/D; mmp14bD/D fish (hereafter
referred to as mmp14a/b KO) developed a gradually worsening
phenotype, first noticed around 30 days post-fertilization (dpf)
and most striking at adult age. Other genotypes were not associ-
ated with any overt abnormalities. The double KO phenotype
includes decreased total body length (20.6 versus 32.5 mm for
WT at 90 dpf, P< 0.0001), a relatively small head showing dorsal
hyperextension in most individuals (86% versus 0%, P< 0.0001),
exophthalmos, a short operculum, and thoracic hyperkyphosis
(Fig. 3A and B). Although mmp14a/b KO fish are born at
Mendelian ratio, they have a shortened average life span of
about 4.5 months and fail to reproduce. Microcomputed tomog-
raphy (mCT) at 90 dpf revealed that mmp14a/b KO fish have a sig-
nificantly reduced skull bone mineral density (BMD, 891.5
versus 959.0 mg/cc, P< 0.05) compared with WT fish (Fig. 3C and
D), and confirmed Weberian-prehemal hyperkyphosis (angle
formed by line connecting center of Weberian vertebral bodies
with line connecting prehemal vertebral bodies is 40.7 in
mmp14a/b KO fish versus 13.8 in WT, P¼ 0.0002). Overall, our
mmp14a/b KO fish recapitulates key aspects of WS and previous
murine Mmp14 mutant and KO models (1,16–18,31–33).
mmp14a/b KO fish have abnormal endochondral and
membranous ossification
Next, we sought to identify the disturbed process(es) underlying
the mmp14a/b KO skeletal phenotype. At 5 dpf, larval craniofa-
cial cartilage elements are qualitatively normal in size and
shape (Supplementary Material, Fig. S6A and B). Subsequent
mineralization of the larval axial skeleton proceeded at a nor-
mal pace (Supplementary Material, Fig. S6C–E). At 30 dpf, the
first differences in calvaria shape became apparent (Fig. 4A).
Mid-sagittal sections of 90 dpf fish stained with hematoxylin
and eosin (H&E) revealed irregular undulation of the membra-
nous ossifying frontal and parietal bones of mmp14a/b KO fish,
containing cell clusters giving these bones a threadbare appear-
ance (Fig. 4B). The membranous ossifying jawbones contain a
relatively small amount of peripheral bone matrix and a disor-
ganized cartilage core (Fig. 4C). Similar abnormalities are seen
in the endochondral ossifying supraoccipital bone (SOC), with
additional cell-free areas in the cartilage core, devoid of proteo-
glycans (Fig. 4E) (34). The relative absence of bone matrix likely
accounts for the low skull BMD of mmp14a/b KO fish. Another
striking finding in mmp14a/b KO fish is the ventral extension of
the SOC and second supraneural, focally compressing the spinal
cord against the first Weberian vertebral body (Fig. 4D). The
resulting compromise of spinal cord integrity might contribute
to the shortened lifespan of KO fish. This interpretation is sup-
ported by observations of an abnormal swimming pattern char-
acterized by tumbling movements, typically observed in KO fish
1–2 days prior to death (Supplemental Material, Movie S1).
Picrosirius red (PSR) staining of additional sections revealed ab-
normal collagen content of jawbones and the SOC of mmp14a/b
KO fish, those bones lacking the collagen-rich cortex observed in
WT fish (Fig. 4E and Supplementary Material, Fig. S7). Polarized
differential interference contrast imaging of PSR stained sections
revealed no overt differences in birefringence, suggesting colla-
gen deposition is unaffected by mmp14a/b KO (Supplementary
Material, Fig. S7) (35). Finally, membranous ossifying Weberian
vertebral bodies in mmp14a/b KO fish were irregularly shaped,
with clusters of multinucleated cells in their dorsal aspect
(Fig. 4G). Taken together, these findings highlight the importance
of Mmp14-dependent collagen remodeling in bone formation.
Discussion
Our in vitro results, summarized in Table 1, provide evidence
that a mild manifestation of WS as observed in our patients is
caused by a novel homozygous missense mutation that par-
tially impairs the catalytic activity of MMP14. Our observations
Figure 3. The mmp14a/b KO zebrafish recapitulate key aspects of the WS phenotype. (A) Gross anatomy photographs of 3-month-old WT and mmp14a/b KO fish of re-
spective average size; lateral view, anterior to the left. The phenotype of mmp14a/b KO fish includes a relatively small, up-tilted head with relatively large, protruding
eyes and a short operculum. Limited field of view necessitated stitching of multiple photographs together, causing the vertical line in the images shown in (A). Scale
bar equals 2 mm. (B) At 90 dpf, mmp14a/b KO fish have a significantly shorter total body length compared with WT fish (P<0.0001). A minimum of 21 individuals per ge-
notype was measured. (C) 3D reconstruction of mCT scans of 3-month-old WT and mmp14a/b KO fish; lateral view, anterior to the left. Compared with WT fish, the
mmp14a/b KO fish have Weberian-prehemal hyperkyphosis. (D) The mmp14a/b KO fish have a reduced skull bone mineral density (BMD, P<0.05), giving the appearance
of missing skeletal elements in the shown 3D reconstruction (C). BMD was assessed for five individuals per genotype. The individuals imaged in (C) are different from
the ones shown in (A).
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Figure 4. The mmp14a/b KO zebrafish have abnormal enchondral and membranous ossifying skull bones and Weberian vertebrae. (A) Fluorescence microscopy images of 30 dpf
WT and mmp14a/b KO juveniles, whole mount stained for calcified bone with alizarin red; lateral view, anterior to the left. At 30 dpf, the frontal bones (arrowhead) and the supra-
occipital bone (SOC, arrow) of mmp14a/b KO fish are shaped differently compared with age and size-matched (10.2 mm standard length) WT fish. (B–E) H&E stained mid-sagittal
sections of 90 dpf fish; anterior to the left except for the mmp14a/b KO section shown in (E), which is rotated (anterior at the bottom) for clearer comparison with the correspond-
ing WT section. At 90 dpf, the frontal bones (B) of mmp14a/b KO fish are irregularly thickened and contain cell clusters (arrowheads). The dentary bone (C) and SOC (E) of mmp14a/
b KO fish contain a relative large amount of disorganized cartilage and small amounts of bone matrix (arrowheads). The SOC additionally shows cell-free areas that have lost
basophilia, indicating lack of proteoglycans (E, asterisks). The SOC and second supraneural (SN2) form a sharp angle and are ventrally extended in mmp14a/b KO fish, impinging
the spinal cord (SC) at the foramen magnum (FM, compare diameter indicated by black line in D). (F) Sagittal picrosirius red stained sections of the same fish as shown in (E)
(same orientation as in (E) reveal the SOC of mmp14a/b KO fish lacks a collagen-rich peripheral bone matrix, but instead contains large cell-rich areas (arrowheads) as compared
with WT fish. In contrast, cell-free regions in the cartilage core of mmp14a/b KO fish are relatively intensely stained. (G) H&E stained mid-sagittal sections (anterior to the left)
demonstrating Weberian vertebral bodies of 90 dpf mmp14a/b KO fish are irregularly shaped and contain cell clusters (arrows), while the intervertebral cartilage is absent (arrow-
head) compared with WT fish. Scale bar in (A) equals 1 mm, scale bars in (B), (C), (E) and (F) equal 20 mm, scale bar in (D) equals 200 mm, scale bar in (G) equals 100 mm.
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suggest that MMP14’s ability to activate pro-MMP2 may be
the most important determinant of disease severity in humans,
as T17R seemed to affect both gelatinase activity and cell
migration to a lesser extent than R111H, whereas it completely
abrogated pro-MMP2 activation. The importance of MMP2 is
underscored by previous reports that its loss can also cause WS
and highly similar phenotypes (11,36,37).
Our findings on MMP14 processing are largely in line with
previous work, however, some seem contradictory. In contrast
to previous observations, we did not observe T17R at the cell
membrane. This apparent discrepancy might be owing to
greater sensitivity of the surface biotinylation assay employed
by Evans et al. when compared with our immunofluorescent de-
tection (12). Our findings on the murine disease-causing R92C
mutation seem to contradict previously published observations
that the R89–R–P–R–C site is shielded from furin, and that the
mature enzyme is generated by cleavage at the R108–R–K–R–Y
motif (13). Rather, R92C seems to abolish prodomain cleavage.
Accordingly, pro-MMP2 activation and gelatinase activity
were abrogated and the protein’s ability to support migration
impaired.
While our observations on T17R, R92C and R111H are consis-
tent with the prodomain’s known role in MMP14 trafficking
and activity, the effects of S466P are less easily explained. As
expected from a damaging missense mutation in the fourth
blade of the Hx domain, it had a pronounced effect on protein
processing and trafficking. Yet, the mutant protein showed only
reduced activity in gelatin zymography and almost normal ac-
tivity in the gelatin invadopodia assay. The mutation also did
not affect MMP14’s ability to support cellular migration. The
most straightforward explanation seems to be that there is suf-
ficient protein still present at the cell surface for the cells to re-
tain near-normal activity in our assays. This is consistent with
previously published data showing some membrane localiza-
tion of MMP14 after its Hx domain had been deleted or swapped
out for that of MMP17 (38). We do not yet know how to reconcile
the severe Cartoon phenotype, which so strongly resembles that
of Sabe, or a full Mmp14 KO, with near normal activity of the
S466P mutant. As a possible explanation, we suggest that this
mutation might affect functionality of other cell types, such as
macrophages and osteoblasts, to a greater extent than that of
fibroblasts.
To further assess the effects of loss of MMP14’s catalytic
function on the organismal level, we generated a zebrafish
mmp14a/b KO model. Our in vivo results support an important
role for MMP14 in collagen remodeling during ossification.
Similar to existing mouse models, the mmp14a/b KO fish recapit-
ulates essential aspects of the WS skeletal phenotype including
a short stature, craniofacial malformations, reduced bone den-
sity and abnormal spinal curvature (1,16,18,20,31–33). Although
the humans, mice and zebrafish all have shortened life spans,
the cause of death differs between species. Where WS patients
reportedly die from heart failure, the mice succumb to wasting,
possibly resulting from malnutrition owing to the facial abnor-
malities (17,18,31–33). Although feeding problems could contrib-
ute to the death of mmp14a/b KO fish, spinal cord impingement,
not observed in humans and mice, seems to be the main cause
of death.
In contrast to previous morpholino studies in zebrafish,
mmp14a/b KO larvae developed normal craniofacial cartilage
elements (25,27). Subsequent mineralization of the larval skele-
ton during metamorphosis proceeded normally as well, and the
first subtle differences in skull shape only became apparent at
juvenile age. The gradually worsening phenotype observed in
humans, mice and zebrafish further suggests that loss of
MMP14 disrupts later stages of skeletal remodeling. Consistent
with our in vitro data, these observations argue against a major
role for MMP14 supporting cellular migratory and invasive be-
havior in vivo. Although the presence and effect of maternal
transcripts in our mmp14a/b KO fish cannot be ruled out, the
normal skeletal patterning in WS patients and Mmp14 KO mice
supports this notion.
Apart from species-specific differences in bone morphology
and ossification mechanisms, the skeletal abnormalities in
mmp14a/b KO fish are comparable to those observed in Mmp14
KO mice. Similar to the mice, both endochondral and intra-
membranous ossification is impaired in mmp14a/b KO fish (33).
During these types of ossification, bone forms within, respec-
tively in close association with, a cartilage template (39,40). It
was shown in Mmp14 KO mice that these cartilage templates
are not properly replaced, respectively removed, owing to im-
paired MMP14-dependent collagen remodeling (32,33,41). This is
reflected in the mmp14a/b KO fish, where cartilage cores of skull
bones are relatively large, disorganized and have altered colla-
gen content, with bone matrix being relative sparse. The cell-
filled lacunae in mmp14a/b KO fish calvariae are reminiscent of
the excessive osteoclastic bone resorption in Mmp14 KO mouse
parietal bone (32–34,40,41). Impairment of additional processes
that depend on MMP14’s catalytic activity, including stimulating
osteoblast differentiation and activity while having an opposite
effect on osteoclasts, might contribute to the mmp14a/b KO skel-
etal phenotype (33,41–44). Further studies are needed to assess
to which extent these processes underlie the skeletal abnormal-
ities in mmp14a/b KO fish.
Taken together, our in vitro and in vivo studies highlight the
significance of impaired proteolytic MMP14 activity underlying
the WS skeletal phenotype. This observation has therapeutic
implications. Attempts have been made in the past to treat WS
and related disorders with bisphosphonates, with limited suc-
cess (45,46). Bisphosphonates exert their therapeutic effect
mostly by inhibiting osteoclasts (47). Whereas our observations
as well as previously published work do support a role for
Table 1. Overview of the effects of studied MMP14 mutations on MMP14 processing and subcellular localization, pro-MMP2 cleavage, gelatin
degradation and cell migration
MMP14 MMP14 processing MMP14 localization Pro-MMP2 cleavage Gelatin degradation Cell migration
WT     
T17R     #
R92C     #
R111H   # # #
S466P  # #  
Tick mark, unaltered; arrow, impaired; cross, severely impaired to absent.
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osteoclasts in the WS bone phenotype, the major problem
seems to be defective collagen remodeling. Thus, we would pro-
pose that any treatment of WS should seek to address this fun-
damental issue. Our zebrafish model could be used to develop
and test such treatments, which might also be able to address
osteoporosis and other conditions with decreased bone density.
Materials and Methods
Cell culture
MRC-5V1 immortalized human fetal lung fibroblasts were pro-
vided by Prof. Alan Lehmann (University of Sussex, Brighton,
UK). HT-1080 fibrosarcoma cells were provided by Dr John
Eykelenboom (University of Dundee, Dundee, UK). Cells were
grown in 2D culture in high glucose Dulbecco’s Modified Eagle
Medium (DMEM, GE Healthcare Life Sciences, Pittsburgh, PA,
USA; SH3024.01), containing 10% (v/v) fetal bovine serum (FBS;
GE Healthcare Life Sciences; A15-101), 100 U/ml penicillin
and 100 mg/ml streptomycin (ThermoFischer Scientific, Inc.,
Waltham, MA, USA; 15140122) at 37C in 100% humidity and 5%
CO2. Cells were kept growing in log phase and passaged when
reaching 70–85% confluence by detaching cells with 0.25% tryp-
sin–EDTA (ThermoFischer Scientific, Inc.; 25200-056).
Cloning and mutagenesis
A series of expression vectors was created encoding 3HA and
EGFP double-tagged versions of either WT or mutant human
MMP14. The MMP14 WT vector was generated by amplifying
MMP14 (RefSeq NP_004986.1) from total cDNA obtained from
MRC-5V1 cells (see Supplementary Material, Table S1 for pri-
mers used) using KOD high fidelity polymerase (Merck) and
cloning the amplicon into the pJET3.1 vector (ThermoFisher).
MMP14 WT cDNA was cloned into the pQCXIB (w297-1, Addgene
plasmid #22800) backbone (a gift from Dr Eric Campeau) with
addition of 3HA and EGFP tags in subsequent cloning steps. The
WS R111H mutant vector was generated by site-directed muta-
genesis (SDM) of Codon 111 of the MMP14 cDNA sequence in the
WT vector from CGC into CAC using partially overlapping pri-
mers following the protocol of Werler et al. (48). Likewise, the
Cartoon S466P mutant vector was generated by SDM of Codon
466 from TCA into CCA. The WS T17R mutant vector was cre-
ated by SDM of Codon 17 from ACG into AGG with fully overlap-
ping primers (see Supplementary Material, Table S1). Likewise,
the Sabe R92C mutant vector was created by mutating Codon 92
from CGA into TGC with fully overlapping primers. The 3HA–
EGFP control vector was generated by deletion of the MMP14
coding sequence from the WT vector by inverse-PCR with fully
overlapping primers binding to 24 bp of each linker sequence.
Four expression vectors encoding either WT or mutant
mmp14a or mmp14b with a C-terminal HA tag were generated.
cDNA was obtained from 2-month-old WT and mmp14aD/D;
mmp14bD/D fish, respectively, as described below and, respec-
tively, WT or mutant mmp14a/b coding sequence PCR amplified
with the primers listed in Supplementary Material, Table S2.
The forward primers started with zebrafish-optimized kozak se-
quence 50-CCAACC-30, the reverse primer ended with the HA
coding sequence. The amplicon was gel-extracted and cloned
into the pCR2.1 TOPO TA vector (Thermo; 450641) according to
the manufacturer’s protocol. The kozak-mmp14a/b-HA insert
was subsequently cloned into the pCS2þbackbone.
Immunofluorescence microscopy
Cells were seeded on No. 1.5H microscope cover glasses (Paul
Marienfeld GmbH & Co. KG, Lauda-Ko¨nigshofen, Germany;
0117580) in 12-well cell culture plates (Corning, Inc., Corning,
NY, USA; 353043) at a density of 50 000 cells per well. Cells were
transfected with 1.2 mg vector DNA using jetPRIMEVR (Polyplus-
transfectionVR SA, Illkirch, France; 114-15) 24 h post-seeding and
media refreshed 4 h post-transfection. Non-transfected cells
were seeded 18 h prior to fixation. Cells were fixed with 4% para-
formaldehyde (PFA) in PBS 1 (Santa Cruz Biotechnology, Inc.,
Dallas, TX, USA; sc-281692), permeabilized with 0.2% TritonVR
X-100 (Promega, Madison, WI, USA; H5141) in PBS 1 (GE
Healthcare Life Sciences; SH30028.02) and blocked with
Image-iTVR FX Signal Enhancer (ThermoFisher Scientific, Inc.;
R37107). Cells were incubated with primary antibodies (see
Supplementary Material, Table S3 for antibody details and dilu-
tions) overnight at 4C, and with Alexa-fluorophore labeled sec-
ondary antibodies (1:200) and phalloidin (1:100) (ThermoFisher)
for 1 h at RT, all dissolved in 3% (w/v) bovine serum albumin
(BSA; MP Biomedicals, Santa Ana, CA, USA; 0219989880) in PBS
1. Cells were mounted on microscope glasses (Biomedia,
Singapore, Singapore; BMH.880102) using Vectashield antifade
mounting medium containing 4’,6-diamidino-2-phenylindole
(Vector Laboratories, Burlingame, CA, USA; H-1200). Z-stacks of
cells were recorded using an Olympus IX81 microscope with
FV1000 scan head (Olympus Corporation, Tokyo, Japan). Images
of randomly selected cells with average signal intensity were
taken with a 63 1.45 NA oil immersion Plan Apochromat objec-
tive (Olympus), with fixed laser power and exposure time per
experiment. The investigator taking and analyzing images was
blinded for the transfection of the cells. Raw images were proc-
essed with Fiji software (U.S. National Institutes of Health,
Bethesda, Maryland, USA; ImageJ version 2.0.0-rc-15/1.49k,
adapted by IMU).
Western blotting
For endogenous MMP14 and analysis of double-tagged MMP14,
cells were seeded at a density of 100 000 cells per well of a six-
well plate. Cells were either transfected with pQCXIB vectors as
described above or left non-transfected. Cells were harvested
using trypsin–EDTA and whole cell lysate (WCL) was obtained
using NP-40 lysis buffer (150 mM NaCl, 1% NP-40, 250 mM Tris
pH 7.3) supplemented with protease and phosphatase inhibitors
(Roche). Protein concentration was determined by Bradford pro-
tein assay (Sigma). An appropriate volume of Laemmli sample
buffer was added to equal amounts of total protein lysate
followed by boiling for 5 min. Samples were subjected to
SDS–PAGE electrophoresis before transfer to an Amersham
HybondTM-PVDF membrane (GE Healthcare Life Sciences,
Buckinghamshire, UK). Membranes were blocked in 5% (w/v)
milk (Marvel dried skimmed milk) in 0.1% (v/v) Tween-20
(Melford; P1362) in TBS 1 (Sigma; T5912-1L). After overnight in-
cubation at 4C in primary antibody (see Supplementary
Material, Table S3) appropriately diluted in 0.5% BSA in TBS
block buffer, membranes were incubated with secondary
IRDyeVR 680RD donkey anti-rabbit (LI-COR Biosciences, Lincoln,
Nebraska, USA; 926-68073) and Alexa fluor 680 donkey anti-
mouse (Thermo; A10038) antibody appropriately diluted in
block buffer. Blots were imaged on the OdysseyVR Fc Imaging
System (LI-COR).
For analysis of the effect of mmp14a/b frameshift mutations
on putative protein products, 400 000 MRC-5V1 cells were
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seeded in 6 cm dishes. Cells were transfected 24 h post-seeding
with 8 lg pCS2þvector or left non-transfected using
InvitrogenTM Lipofectamine 3000 (Thermo; L3000008) according
to the manufacturer’s protocol. Media was refreshed 6 h post-
transfection. Cells were harvested 24 h post-transfection using
trypsin–EDTA and WCL obtained using TritonVR X-100 lysis
buffer [50 mM Tris–HCl pH 7.5, 150 mM NaCl, 1% (v/v) TritonVR
X-100, 10% (v/v) glycerol, 0.1% (w/v) deoxycholate, 25 mM b-glyc-
erophosphate] supplemented with protease inhibitors (Roche)
and phosphatase inhibitors (10 mM NaF and 1 mM Na3VO4).
Protein concentration was determined by Bradford protein as-
say. Samples were mixed with Laemmli sample buffer and
boiled as described above. Samples were subjected to SDS–PAGE
electrophoresis before transfer to a PVDF membrane (Merck;
ISEQ00010). Membranes were blocked in 5% (w/v) milk (Biorad;
170–6404) in 0.1% (v/v) Tween-20 in TBS 1 and incubated with
rabbit anti-HA (Cell Signaling Technology, Inc., Danvers, MA,
USA; 3724) or rabbit anti-b-actin (Cell Signaling; 4967) primary
antibodies at 1:1000 or 1:4000, respectively, in 5% (w/v) milk in
0.1% (v/v) Tween-20 in TBS 1. Membranes were incubated with
horseradish peroxidase-conjugated goat anti-rabbit secondary
antibody (1:3000) and Streptactin (1:10 000) in 4% (w/v) milk in
0.1% (v/v) Tween-20 in TBS 1. Protein bands were visualized by
ECL Western Blotting substrate mix (Thermo; 32106) on the
BioRad ChemidocTM and gel images edited in Image LabTM 5.1
build 8 software (Biorad).
Zymography
Gelatin zymography was performed as previously described
(49). Briefly, MRC-5V1 cells were transfected with the aforemen-
tioned pQCXIB vectors. Culture medium was changed to FBS-
free DMEM 24 h post-transfection to allow conditioning for 24 h,
after which conditioned medium was harvested and mixed
with equal volumes of 2 sample buffer [0.125 M Tris–HCL, pH
6.8, 20% (v/v) glycerol, 4% (w/v) SDS, 0.005% (w/v) bromophenol
blue (Sigma; B-6131)]. Samples were subjected to SDS-PAGE
electrophoresis in 10% resolving gel containing 0.1% gelatin.
After electrophoresis, proteins were renatured in freshly made
1 Zymogram Renaturing Buffer [Triton X-100 2.5% (v/v) in
ddH2O] for 30 min at RT. The gel was subsequently incubated in
1 Zymogram Developing Buffer [0.01 M Tris–HCL pH 7.5
(Sigma; 10812846001), 1.25% (v/v) Triton X-100, 5 mM CaCl2
(Kanto Chemical Co., 07058-00)] for 30 min at RT to allow equili-
bration. Developing buffer was refreshed and the gel was incu-
bated at 37C overnight. Finally, the gel was stained with
Coomassie Blue R-250 (Thermo; 20278) 0.5% (w/v) for 30 min,
and subsequently washed in destaining solution (water:metha-
nol acetic acid at 5:4:1) for 4 times 15 min. The gel was imaged
with the Bio-Rad Image Lab system and the image analyzed in
Fiji software.
Gelatin digestion assay
The QCMTM Gelatin Invadopodia Assay system (Merck Millipore,
Billerica, MA, USA; ECM671) was used according to the manufac-
turer’s protocol. In brief, a four-chamber glass bottom dish
(Cellvis, Mountain View, CA, USA; D35C4-20-1.5-N) was coated
with poly-L-Lysine, glutaraldehyde and Cy3-labeled gelatin in
sequence. The coated dish was sterilized with 70% ethanol for
30 min, followed by DMEM quenching for 30 min at RT. MRC-
5V1 cells were transfected with the appropriate pQCXIB vectors
24 h prior to seeding onto the coated chamber dish. The ability
of the transfected cells to digest the Cy3-labeled gelatin was de-
termined at 3 and 20 h post-seeding using an EVOS fluorescence
microscope (Thermo; AMF4300). Average degradation per green
fluorescent cell (degradation factor, d) was calculated by auto-
mated image analysis in Fiji and assessed for statistical differ-
ence by a two-sided student’s T-test in MicrosoftVR ExcelVR
[Microsoft Corporation, Redmond, WA, USA; version 14.6.6
(160626)]. To quantify the number of transfected cells (N) in a
given field, a find-object macro was created in Fiji. Threshold
was manually adjusted to cover the entire degradation area (A)
that was measured. The degradation factor of each MMP14 mu-
tant was defined as d¼A/N. Three independent experiments
(N103) were carried out. For qualitative analysis, fluorescent
cells were identified 2 h post-seeding and z-stacks recorded
ever 15 min for 5 h with a spinning disk (Yokogawa, Tokyo,
Japan; CSU-22) confocal microscope (Nikon, Tokyo, Japan; Nikon
Ti inverted) equipped with the Nikon Perfect Focus System. A
maximum intensity projection was performed in MetaMorph
7.8.8.0 software (Molecular Devices, Sunnyvale, CA, USA) at the
end of the experiment.
Phagokinetic assay
Four-chamber glass bottom dishes were coated with 1 lg/ml
Rhodamine Fibronectin (Cytoskeleton, Denver, CO, USA; FNR01)
according to the manufacturer’s protocol. MRC-5V1 cells were
transfected with the aforementioned pQCXIB vectors 24 h prior
to seeding onto the coated chamber dish. Migration of the trans-
fected cells was recorded by time-lapse imaging starting 2 h
post-seeding with a spinning disk confocal microscope. A
z-stack consisting of 16 steps with an interval of 1 lm between
successive steps of each field was acquired and a maximum
intensity projection was performed in MetaMorph software.
Time-lapse images were then subjected to customize cell-
tracking analysis in Imaris Image Analysis Software 8.4.1
(Bitplane, Belfast, UK).
Zebrafish husbandry
Danio rerio larvae of the AB strain were grown in E3 medium
(0.1 mM NaCl, 3.4 mM HCl, 6.6 mM CaCl2, 6.6 mM MgSO4, pH 7.4)
at 28.5C at a rearing density of 80–100 individuals per liter until
14 dpf, after which larvae were transferred to a closed
water system at a density of 13–16 individuals per liter. Feeding
schedule was fixed according to the age of the fish; light/dark
(14 h/10 h) circadian rhythm remained fixed from 5 dpf on-
wards. From 4 weeks of age onwards, fish were kept at 27.5C.
All zebrafish experiments were conducted under IACUC license
140924.
Genomic editing ofmmp14a andmmp14b by
CRISPR/Cas9
Optimal CRISPR genomic target sites in mmp14a (RefSeq
NP_919397.1) and mmp14b (RefSeq NP_919395.1) were identified
by ZiFiT Targeter Version 4.2 (Zinc Finger Consortium; URL:
zifit.partners.org/ZiFiT; date last accessed May 2014), ordered as
gBlocksVR Gene Fragments (Integrated DNA Technologies,
Coralville, IA, USA), PCR amplified and transcribed into gRNA
with the InvitrogenTM MEGAshortscript T7 kit (ThermoFischer
Scientific, Inc.; AM1354) according to the manufacturer’s proto-
col (50,51). Cas9 RNA was generated by transcribing NotI-linear-
ized pCS2-nls-zCas9-nls vector (Addgene, Cambridge, MA, USA;
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47929) with the InvitrogenTM mMESSAGE mMACHINETM SP6
Transcription Kit (Thermo; AM1340) according to the manufac-
turer’s protocol (52). Danio rerio zygotes were micro-injected in
the yolk cell with 2.5 nL 1 Danieau’s solution [58 mM NaCl,
0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM Ca(NO3)2, 5.0 mM HEPES, pH
7.6]/1 PhenolRed (Sigma; P0290) in dH2O containing 0.375 ng
Cas9 RNA and 0.375 ng mmp14a gRNA or 1 ng mmp4b gRNA as
previously described (53). Genomic editing was assessed by lysis
of 24 hpf embryos or juvenile/adult fin-clips [in 10 mM Tris,
50 mM KCl, 0.3% (v/v) Tween-20, 0.3% (v/v) NP-40, and 0.488 mg/
ml proteinase K in dH2O; pH 8.3] and direct Sanger sequencing
of a 200–500 bp gDNA amplicon encompassing the target site
using Bigdye Terminators version 3.1 (Thermo; 4337455) and a
3730XL sequencer (Thermo). Chromatography reads were ana-
lyzed for frameshift mutations with Poly Peak Parser web tool
(Yost Lab, Salt Lake City, UT, USA) and checked manually in
SnapGene version 3.3.4 (Clontech Laboratories, Mountain View,
CA, USA) (54). Three-month-old F0 mosaic mutants were inter-
crossed and their F1 offspring genotyped at 2 months of age to
identify fish with heterozygous frameshift mutations in
mmp14a or mmp14b. F1 mmp14aþ/D fish were outcrossed with F0
mmp14b founders to generate F2 mmp14aþ/D; mmp14bþ/D fish,
that were subsequently intercrossed to generate all possible
mmp14a/b genotypes in the F3 generation.
qPCR verification ofmmp14a/b KO
Twenty 1–5 dpf larvae per genotype were pooled per time point,
homogenized in Trizol (Thermo; 15596018), and total mRNA was
chloroform/isopropanol precipitated and rinsed with ice-cold
75% (v/v) ethanol in diethyl pyrocarbonate treated water (Sigma;
159220). mRNA was resuspended in RNase-free water, DNase
treated (Thermo; AM2238) and cleaned-up with the RNeasy Mini
Kit (Qiagen; 74106). cDNA was synthesized with the High-
Capacity cDNA Reverse Transcription Kit (Thermo; 4368813) and
qPCR was performed with SYBRTM Select Master Mix (Thermo;
4472919), all according to the manufacturers’ protocols. Primers
listed in Supplementary Material, Table S4 were tested at differ-
ent concentrations (1.95–500 nM) for qPCR on cDNA of 24 hpf
WT embryos in technical triplicate with SYBRTM Select Master
Mix according to the manufacturer’s protocol. Generation of a
single amplicon was verified by direct Sanger sequencing.
Expression of mmp14a/b was normalized to b-actin (and
expressed relative to the expression level at 1 dpf for larvae).
Gross anatomy of larvae, juveniles and adult zebrafish
Fish were sedated with 200 lg/ml ethyl-3-aminobenzoate meth-
anesulfonate (Tricaine/MS222; Sigma; A5040) in system water
buffered to pH 7.0–7.5 with NaHCO3 (Sigma; S5761) and imaged
on moist filter paper with an MZ16 FA fluorescence stereomicro-
scope (Leica, Wetzlar, Germany) and DFC 300 FX Digital Color
Camera (Leica) at 1.4 MPixel resolution at 7.11 and 14 magni-
fication (55). Images were stitched together in Pixelmator 3.5
Canyon software (Pixelmator Team, Vilnius, Lithuania). Total
body length was measured using Fiji software, and differences
in mean total body length between genotypes were tested for
significance by two-sided Student’s t-test. The number of fish
with dorsal tilting of the head was analyzed by the Fisher Exact
test in SPSS software version 22 (IBM, Armonk, NY, USA).
Microcomputed tomography
Three-month-old fish were euthanized by hypothermic shock
and fixed in 4% PFA and dehydrated through graded water into
ethanol. Average sized fish were fixed per genotype, except
for mmp14aD/D; mmp14bD/D for which larger individuals were
selected to better match the size of other genotypes.
Microcomputed tomography images were acquired using an
Inveon CT (Siemens AG, Berlin, Germany) at 55 kVp/110 mA.
The exposure time per projection was 2500 ms and a binning
factor of 2 was used, resulting in a reconstructed pixel size of
35 lm. Planar images were acquired from 181 projections over
360 of rotation in step-and-shoot mode. The images were
reconstructed using a Feldkamp cone-beam algorithm. Three-
dimensional renders of the skeleton were made with AMIRA
software (FEI, Me´rignac Cedex, France) with constant window
settings. Images were exported as TIFF files and extracorporeal
skeletal elements of previously imaged fish were manually re-
moved with Pixelmator software. Raw data were viewed with
AMIDE-bin 1.0.5 software (Andreas Loening), individual virtual
sections exported as TIFF files and angles measured in Fiji soft-
ware. Differences in mean bone density and angle of kyphosis
between genotypes were tested for significance by two-sided
Student’s t-test.
Histology
Three-month-old fish were euthanized and fixed as described
above. After trimming, the fish were placed into cassettes and
processed with Sakura VIP Tissue Processor. Fish were dehy-
drated through graded ethanol into xylene (Chemtech Trading)
before paraffin (Leica; 39601006) infiltration. After processing,
tissues were embedded into paraffin blocks and sectioned mid-
sagittally with a rotary microtome into 5 lm thick sections. The
slides with sections were dried and placed into an incubator
(60C, 15 min). The sections were deparaffinized and rehydrated
through graded ethanol into water. Rehydrated sections were
subjected to hematoxylin solution (Richard-Allan ScientificTM;
7231), Bluing (Richard-Allan ScientificTM; 7301), Clarifier
(Richard-Allan ScientificTM; 7442) and eosin-phloxine B Solution
(AMPL). A separate batch of 5 lm thick sections of all the sam-
ples were stained with Weigert’s hematoxylin, followed by
Picrosirius red 0.1% (w/v) staining and rinsing with two changes
of acidified (0.5%) water. Stained sections were dehydrated
through graded ethanol into xylene and a cover slip added.
Slides were imaged with an automated slide scanner equipped
with Zeiss AxioImager Z.2 body, MetaSystems stage, Zeiss Plan-
Neofluar 20/0.5 Ph2 lens, SSCOPED TL light source, CoolCube 1
camera with 1.4 Mpixel resolution controlled by Metafer4 soft-
ware. Images were viewed with VSViewer V2.1.103 software
(MetaSystems GmbH, Altlussheim, Germany).
Whole mount cartilage and calcified bone staining
Larvae were stained for cartilage and calcified bone according to
a protocol adapted from Walker et al. (56). Larvae were culled by
overdose of Tricaine, fixed in 4% PFA for 2 h at RT and dehy-
drated in 50% (v/v) ethanol. Larvae were stained with either
0.02% (w/v) Alcian blue 8 GX (Sigma; A5268)/60 mM MgCl2 or
40 lg/ml 3,4-dihydroxy-9,10-dioxo-2-anthracenesulfonic acid
sodium salt (alizarin red, Sigma; A5533) in 70% (v/v) ethanol for
14 h at RT. Larvae were rehydrated in 50% ethanol (v/v). Thirty
dpf alizarin red stained larvae were de-stained in 1% (w/v)
KOH for 45 min at RT. All larvae were bleached with 1.5% (v/v)
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H2O2/1% (w/v) KOH for 20 min at RT. Larvae were cleared by go-
ing through successive stages (20–50%, v/v) of glycerol. Fourteen
days post-fertilization alizarin red stained larvae and picrosirius
red stained sections were imaged with a Zeiss AxioImager M2
upright fluorescence microscope with X-CiteVR 120Q (120 W) light
source (Excelitas Technologies Corp., Waltham, MA, USA),
dsRed filter, DIC polarizer and Zeiss Plan-Neofluar 5/0.16 NA,
10/0.3 NA and 20/0.5 NA lenses. The system was operated
with AxioVision version 4.8.2 SP3 software (Zeiss) and images
were taken with an AxioCam HRc camera (Zeiss) with
1.4 Mpixel resolution. Alcian Blue stained larvae and 21 and
30 dpf alizarin red stained larvae were imaged with a Leica
MZ16FA fluorescence stereomicroscope, equipped with the
Leica CLS150 (for brightfield) and MZ16FA (for fluorescence) light
sources, dsRed filter and Planapo 1.0 lens (Leica; 10447157).
The system was operated with Leica Application Suite software
version 2.5.0 R1 (Build 975) and images were taken with a Leica
DFC 300 FX R2 camera with 1.4 Mpixel resolution. Differences in
mean standard length and vertebral ossification between geno-
types were tested for significance by two-sided Student’s t-test.
Supplementary Material
Supplementary Material is available at HMG online.
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